APG-2575
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
What's the purpose of the trial?
This is a multi-center, single-agent, open-label, Phase I study of APG-2575. The study consists of the dose escalation stage and the dose expansion stage.
Accepting patients
Participating Centers
There are 2 centers participating in this trial. Enter a location below to find the closest center.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.